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ABSTRACT
Background: A greater understanding of mechanisms explaining the interactions between diet
and the gut microbiota in colorectal cancer is desirable. Genotoxic microbial metabolites present
in the colon may be implicated in carcinogenesis and potentially influenced by diet.
Aims: We hypothesised that microbial p-cresol is a colonic genotoxin and set out to model
potential exposures in the colon and the effects of these exposures on colonic cells.
Methods: Batch culture fermentations with human faecal inoculate were used to determine the
synthesis of p-cresol and other metabolites in response to various substrates. The fermentation
supernatants were evaluated for genotoxicity and the independent effects of p-cresol on colonic
cells were studied in vitro.
Results: In batch culture fermentation, supplementary protein increased the synthesis of phenols,
indoles and p-cresol, whereas supplementary fructoligosaccharide (FOS) increased the synthesis of
short chain fatty acids. The p-cresol was the greatest predictor of genotoxicity against colonocytes
in the fermentation supernatants. Spiking fermentation supernatants with exogenous p-cresol
further increased DNA damage, and independently p-cresol induced DNA damage in a dose-
dependent manner against HT29 and Caco-2 cells and influenced cell cycle kinetics.
Conclusions: In the colon p-cresol may reach physiologically significant concentrations which
contribute to genotoxic exposures in the intestinal lumen, p-cresol production may be attenuated
by substrate, and therefore diet, making it a potential modifiable biomarker of genotoxicity in the
colon.
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Introduction
The colon is the most common site for intestinal
tumours1 with microbial activity being implicated
in increased susceptibility to neoplastic
transformation.2 Environmental factors, particu-
larly diet, modulate the composition and meta-
bolic activity of the colonic microbiota with
implications for cancer risk.3,4 Current mechanis-
tic models implicating diet in CRC risk propose
that dietary fibre favourably improves the balance
of the microbiota, increasing the abundance of
saccharolytic species relative to proteolytic
microbes. The latter are associated with increased
production of an assortment of genotoxic metabo-
lites from meat based or endogenous substrates.4–6
Epidemiological studies implicate red and
processed meat in particular in increasing risk of
CRC. Genotoxicity associated with haem,
N-nitroso compounds, and heterocyclic amines
has been proposed as a mechanism underpinning
this association.7 Amongst proteolytic metabolites
present in the colon, p-cresol is a relatively poorly
studied potential contributor to the genotoxic
load.8 p-cresol is a methyl phenol produced via
microbial degradation of tyrosine.9,10 In situ, it is
absorbed and metabolised in the liver, producing
p-cresol sulphate, which is excreted in the urine.
Elevated urinary p-cresol sulphate has been
observed in patients with colorectal cancer10, it
may be associated with ageing11 and more recently
it has been suggested as a biomarker of protein
intake.12
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Due to the efficient intestinal uptake of p-cresol,
and other colonic luminal genotoxins, the geno-
toxicity and chemical composition of faecal sam-
ples may be poorly representative of colonic
exposures; this has, in part, limited the use of
faecal water genotoxicity as a diet-related biomar-
ker of colorectal cancer risk.13 The presence of
p-cresol sulphate in urine and its association with
both diet and the microbiome may make it a
useful, modifiable, diet-sensitive, biomarker of col-
orectal genotoxicity, and therefore potentially of
CRC risk, which could be applied in human inter-
vention studies.12
Here our objectives were two fold, a) to establish
the potential luminal exposure to p-cresol using a
simulated gut fermentation system. b) to determine
the genotoxicity of p-cresol, as part of the colonic
metabolome, at levels of exposure consistent with
those achievable in vivo using two separate cell-
based models of the colonic epithelium.
Materials and methods
Chemicals
p-cresol, agarose, EDTA, Trizma base, Triton
X-100, hydrogen peroxide (H2O2), Hepes, ethi-
dium bromide, propidium iodide (PI) and RNase
A were purchased from Sigma-Aldrich Ltd.
(Dorset UK). Sodium chloride (NaCl) and potas-
sium chloride (KCl) were supplied by Fisher
Scientific (Loughborough, UK).
Tyrosine, fructoligosaccharide (Raftilose P95),
albumin, soybean protein peptone meat extracts
were all purchased from Sigma-Aldrich Ltd.
(Dorset UK). Bacteriological growth medium sup-
plements were obtained from Oxoid Ltd.
(Basingstoke, Hants, U.K.). Probes for fluorescence
in situ hybridisation were commercially synthe-
sised and labelled at the 5′ end with the fluorescent
dye Cy3 (Sigma Aldrich Ltd, Poole, Dorset, UK).
The probes used are listed in Table 1: The HT29
and Caco-2 human colorectal cell lines were
obtained from the European Collection of
Animal Cell Cultures (ECACC) (Salisbury, UK)
Essential Medium (MEM), McCoy’s 5A with
L-glutamate, Penicillin-Streptomycin and Fetal
Bovine Serum (FBS) were purchased from
Biosera Ltd. (East Sussex, UK). Phosphate
Buffered Saline (PBS), Non-essential Amino
Acids (NEAA), Trypsin-Versene and
Ethylenediaminetetraacetic acid (EDTA) were pur-
chased from Lonza group Ltd. (Basel, Switzerland).
Faecal inoculate for batch culture fermentation
Faecal samples were collected from three indivi-
duals (over 60 years of age). All volunteers self-
reported as being healthy, antibiotic-free for at
least 6 months prior to sampling and free from
gastrointestinal disorders. Samples were collected
on the day of the experiment and were used imme-
diately. Upon collection, they were diluted 1:10 (w/
v) with anaerobic PBS (0.1 M; pH 7.4) and homo-
genised in a stomacher for 2 min (460-paddle
beats/min). 15 ml of the resulting faecal slurries
from each individual were used to inoculate batch
culture vessels in triplicate.
Table 1. Primer sequences for fluorescent in situ hybridisation.
Probes name Sequences 5′ To 3’ Target genus Reference
Non Eub (Negative control) ACTCCTACGGGAGGCAGC 14
Eub338 I + (Positive control) GCT GCC TCC CGT AGG AGT Most bacteria 15
Eub338 II + GCA GCC ACC CGT AGG TGT Planctomycetales 15
Eub338 III + GCT GCC ACC CGT AGG TGT Verrucomicrobiales 15
Bif164 CATCCGGCATTACCACCC Most Bifidobacterium spp 16
Lab158 GGTATTAGCAYCTGTTTCCA Most Lactobacillus, Leuconostoc and Weissella spp 17
Bac 303 CCAATGTGGGGGACCTT Most Bacteroidaceae and Prevotellaceae, some Porphyromonadaceae 18
Erec 482 GCTTCTTAGTCARGTACCG Most of the Clostridium coccoides-Eubacterium rectale group 19
Rrec 584 TCAGACTTGCCGYACCGC Roseburia subcluster 20
Chis150 TTATGCGGTATTAATCTYCCTTT Most of the Clostridium histolyticum group
(Clostridium clusters I and II)
19
Prop 853 ATTGCGTTAACTCCGGCAC Clostridial cluster IX 20
Ato 291 GGTCGGTCTCTCAACCC Atopobium, Colinsella, Olsenella and Eggerthella spp. 21
Fprau 647 CGCCTACCTCTGCACTAC Faecalibacterium prausnitzii and related sequences 22
DSV 687 TACGGATTTCACTCC T Most Desulfovibrionales (excluding Lawsonia) and many
Desulfuromonales
23
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Batch culture fermentation
Batch culture fermentation vessels were autoclaved
and filled with 135 ml of basal nutrient medium
(peptone water (2 g/L), yeast extract (2 g/L), NaCl
(0.1 g/L), K2HPO4 (0.04 g/L), NaHCO3 (2 g/L),
MgSO47H2O (0.01 g/L), CaCl26H2O (0.01 g/L),
Tween 80 (2 ml/L), hemin (50 mg/L), vitamin K1
(10 ml/L), L-cysteine (0.5 g/l), bile salts (0.5 g/L),
resazurin (1 mg/L) and distilled water (Sigma,
Aldrich, UK). The vessels were gassed overnight
with O2-free N2 (15 ml/min).
Supplementary substrates
Alternative additional substrates were included to
explore the influence of dietary substrates on p-cresol
fermentation. These were prepared as a high tyrosine
(supplementary tyrosine at 0.3 % w/w), a low tyrosine
treatment (supplementary tyrosine 0.003 % w/w), a
high tyrosine with fructoligosaccharide (FOS) (0.3 %
w/w Tyr + FOS 1.5% w/w), a low tyrosine with FOS
(0.003 % w/w Tyr + 1.5% w/w FOS), an albumin
treatment (0.3% w/w), a soybean protein treatment
(0.3%w/w) and a peptonemeat extract treatment (0.3
% w/w).
Faecal inoculate (15ml) was added to initiate the
cultures and the subsequent fermentation carried
out under anaerobic conditions. The temperature
was maintained at 37°C by use of a circulating
water bath and pH was maintained at 6.8 using a
pH controller (Electro lab, UK). At six time points
(0, 4, 8, 24, 30 and 48 hours), 10 ml of fermenta-
tion supernatant was collected for analysis.
Fermentation supernatants were filter sterilised
through a 0.2 mm PVDF single use filter
(Sartorius Ltd. Surrey UK) for use as microbe-
free treatments in cell culture experiments.
All fermentation conditions were conducted in
triplicate, each time with a different donor- then to
eliminate variability associated with the starting
culture, fermentations with inoculate from one
single donor were repeated three times.
Bacterial enumeration
Fluorescence in situ hybridisation
Bacterial populations from the batch culture sam-
ples were enumerated using fluorescence in situ
hybridisation and flow cytometry (Flow-FISH),
with oligonucleotide probes targeting specific
regions of 16S rRNA as described previously.14
Briefly, commercially synthesised probes were
coated with the fluorescent dye, Cy3 (Table 1).
Bacteria from fermentation samples were isolated
via centrifugation, washed in PBS and fixed in 4%
(v/v) paraformaldehyde, they were then washed
and stored at −20◦C in PBS and 99% ethanol
(1:1 v/v). For analysis, bacteria were prepared in
TE-FISH buffer and incubated with lysozyme
(1 mg/mL of 50 000 U/mg protein) for 10 min.
The cells were then washed and hybridisation
completed by incubating the cells in 150 μL of
hybridisation buffer (5 M NaCl, 1 M Tris/HCl
pH 8, 30% formamide, ddH2O, 10% SDS and
4.55 ng ml−1 probe) for 4 hours.
Metabolite characterisation. Standards of p-cre-
sol, phenol and indole were prepared in distilled
water at concentrations from (0.1–1600 mM) and
standard curves plotted following quantification
via solid-phase micro-extraction (SPME) gas chro-
matography mass spectrometry (GC-MS) using an
Agilent 110 PAL injection system and Agilent
7890 gas chromatograph with a 5975C mass spec-
trometer (Agilent, Santa Clara, CA). The SPME
fibre stationary phase was composed of 75 µm
divinylbenzene/Carboxen™ on polydimethylsilox-
ane; Supelco, Bellefonte, PA). Sample (0.1 mL)
was placed in a 20-mL headspace vial with mag-
netic screw cap and PTFE/silicone septum
(Supelco). The samples were allowed to equilibrate
for 10 minutes at 35 °C before being extracted for
30 min. Sample was agitated at 500 rpm (5 seconds
on, 2 seconds off) during equilibration and extrac-
tion. After extraction, the contents of the fibre
were desorbed onto the front of a Stabilwax-DA
fused silica capillary column (30 m 0.25 mm i.e.,
0.50 mm film thickness; Restek, Bellefonte PA).
The GC temperature program and the fibre deso-
rption step commenced at the same time. During
the desorption period (45 s), the oven was held at
40 °C. After desorption, the oven was held at 40 °C
for a further 255 s before incremental heating at
4 °C/min to 260 °C, where the temperature was
maintained for 5 min. Helium was used as the
carrier gas at a constant flow rate of 0.9 mL/min.
The mass spectrometer was operated in electron
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impact mode with an electron energy of 70 eV,
scanning from m/z 20 to m/z 280 at 1.9 scans/s.
Organic acid analysis
Samples from batch culture fermentation were
screened for short-chain fatty acid (SCFA) concen-
trations using the gas chromatography method of
Zhao et al.15 Briefly the fermentation samples were
defrosted, vortexed and centrifuged for 5 minutes at
13400 x g. The samples were filtered using a 0.22 μm
filters into a new Eppendorf tube. 100 µl of the
sample supernatant was added to 260 µl sulphuric
acid solution (20 µl sulphuric acid diluted in 100 ml
of water, pH 2). 200 µl of the sample and 50 µl of
internal standard were prepared in GC vials. The
internal standard was 2-ethylbutyric acid (Aldrich)
in HPLC grade water. The GC apparatus was cali-
brated for detection of acetate, propionate, iso-buty-
rate, butyrate, iso-valeric, valeric and caproic acid.
260 µl sulphuric acid solution was added to 100 µl
(100mM) of each standard. 200 µl of this was
removed to a vial and added to 50 µl of the internal
standard. This was repeated through a range of
concentration between 5–100 mM. A HP 5890 series
II GC system (Hewlett Packard, Palo Alto, Calif)
with an FFAP, capillary fused silica packed column
25 m by 0.32 mm; filter thickness, 0.25µm
(Macherey-Nagel, Düren, Gemany). Afterwards,
the sample was injected into the column, which
was maintained at 140°C for 5 minutes. Then the
column temperature was increased over 5 minutes
to 240°C. The calibrated organic acids were detected
in the samples and the concentration were calcu-
lated. Internal standard with known concentration
of SCFA was injected after every 10 samples to
maintain appropriate calibration. Finally, peaks
were analysed and integrated using HP GC
ChemStation Software, Hewlett Packard.
Cell culture
The HT29 and Caco-2 human cell lines are
derived from colonic epithelial adenocarcinoma
cells and are widely used in cancer research. The
cells were used between passages 45 and 70. HT29
cells were cultured routinely in McCoy’s 5A with
L-glutamate supplemented with penicillin-strepto-
mycin and FBS. Caco-2 cells were cultured in
MEM supplemented FBS and NEAA. Routine cul-
ture was carried out at 37°C with 5% CO2 and 95%
humidity, the cell medium was changed every
2 days with trypsin mediated passage at 80–90%
confluence.
Cell viability
Cell viability was assessed as described previously.14
Briefly, HT29 and Caco-2 cells were seeded at
1 × 106 cells per ml and cultured for 24 hours in
basal media (37 °C, 5% CO2. A concentration curve
of 4 cresol in basal media was established and used
to treat cells for a further 24 hours. Media was then
removed and cells fixed in ice cold methanol, dried
and stained with 4,6-diamidino-2-phenylindole,
dihydrochloride (DAPI) (70 µl of DAPI staining
stock solution (3 mM) plus 10.43 ml of PBS per
plate) Absorption was measured using a GENios
microplate reader (TECAN Group Ltd.,
Männedorf, Switzerland) with absorbance and
emission at 340 nm and 465 nm, respectively. Cell
viability was determined relative to a 0 % p-cresol
control.
DNA damage
HT29 and Caco-2 cells were seeded at concentra-
tions of 1 × 106 and maintained at 37°C in an
atmosphere of 5% CO2 and 95% filtered air. Cells
were treated in the tissue culture flasks at 80%
confluency, with p-cresol at final concentrations
of between 0 and 3 uM, or with filter sterilised
fermentation supernatants prepared at 10% (v/v),
in McCoy’s carrier culture medium with inacti-
vated FBS and antibiotics. The cell cultures were
incubated at 37°C with 5% CO2 and after
24 hours, DNA damage was assessed using the
Comet assay as described previously.16 Briefly, a
positive control was prepared with untreated cells
exposed to 7.5 mM H2O2 for 15 minutes prior to
lysis. Viable cells were counted after trypan blue
staining and adjusted to a concentration of 3 × 106
cells/ml. An aliquot (120ul) of the cell suspension
was mixed with 200 µl of melted agarose and
bedded on microscope slides. The slides were
placed into lysis buffer (2.5M NaCl, 0.1 EDTA,
0.01 M Tris and 1% (v/v) Triton X-100) for 1
hour at 4°C, and then washed 3 times with
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neutralising buffer (0.4M Trizma base pH 7.5)
before transfer into electrophoresis buffer (0.3M
NaOH and 1mM EDTA). After 20 min at 4°C the
slides were placed horizontally in an electrophor-
esis tank containing electrophoresis alkaline buffer
to allow the DNA to unwind. Electrophoresis was
run at 26V, 300mA for 40 minutes in at 4°C in the
dark. The slides were then washed with neutralis-
ing buffer three times for 5 minutes each and left
for 5 minutes in 99% ethanol for 5 minutes, then
left to dry overnight. Cells were stained with ethi-
dium bromide (20ul/ml) and kept for 15 minutes
in the dark. Images of DNA integrity were cap-
tured by fluorescence microscopy using the
Kinetic image software, Komet 4.0 UK. One hun-
dred randomly selected cells from each replicate
slides were evaluated for DNA tail damage by an
analyst blinded to the treatment.
Spiked fermentation supernatants
To determine the genotoxic potential of p-cresol in
the context of the fermentation milieu, selected
filter sterilised fermentation supernatants were
spiked with exogenous 4 cresol at concentrations
of 0.2 or 3 mM and applied to the HT29 cell line
for 24 hours prior to the Comet assay.
Cell cycle assay
Cell cycle progression was assessed considering the
percentage of cells in phases Gap0/1 (G0/G1),
Synthesis (S), Gap2/mitosis (G2/M) and apoptotic
cells (sub G0/G1) according to the fluorescence
intensity of a PI nuclear stain, and based on the
concentration of DNA within the cell. HT29 and
Caco-2 cell cultures were treated at 2 × 105 cells/
well into 6 well plates at 80% confluence. The cells
were exposed to p-cresol at 0.2, 0.5, 1.0, 1.5,
3.0 mM for 24 hours. After removing treatments,
the cells were washed with ice cold PBS and col-
lected following trypsin harvest of the monolayer
and pelleting by centrifugation at 300 G for 3 min-
utes. The supernatants were discarded and then
the cell tissues were resuspended in 200 μl ice
cold PBS and fixed with 2 ml of fresh ice cold
70% ethanol. The cell pellets were stored in freezer
at −20°C until analysis.
After chilling, the samples were centrifuged at
300 G for 5 minutes and the supernatants
discarded. The pellets were resuspended with
200 µl PBS before adding 25 µl of 1 mg/ml
RNAse and the suspensions were then incubated
at 37°C for 30 minutes. 2.5 μl of 400 µg/ml of PI
were added to bind DNA and were left to incubate
for 30 min at room temperature in dark condition.
Cells suspensions were adjusted to a final volume
of 600 µl with PBS. The DNA content of 15,000
cells were then measured immediately via flow
cytometry (BD Accuri C6 flow cytometer,
Germany). Analysis was performed using the
Flow Jo software (Tree star Inc, Oregon, USA).
Statistical analysis
All statistical analyses were carried out using the
Statistical Package for Social Sciences (SPSS) ver-
sion 22. All experiments were carried in three
biological replicates for each analysis and the
data presented as mean ± SEM. Cell viability and
cell cycle data were analysed using linear regres-
sion models. For bacteriology, comparisons
between each volunteers were made by ANOVA.
Similarly the ANOVA was used to compare the
effects of substrates on fermentation sample geno-
toxicity and cell cycle kinetics. Where appropriate
comparison of individual treatments with negative
control were performed using the Dunnett Post-
hoc test.
P values < 0.05 were considered to be statisti-
cally significant between the treatments.
Results
Characterisation of fermentation microbiota
Three faecal donors supplied specimens for the
inter-individual biological replication of batch cul-
ture fermentations. An analysis of the microbial
composition of the fermentation inoculate, was
performed using 16S rRNA adherent molecular
probes. There were statistically significant differ-
ences in the starting microbial composition of the
batch culture fermentations which was reflected by
subsequent inter-individual differences in metabo-
lite production. At baseline, volunteer 1 had a
greater relative abundance of strains staining posi-
tive for the Bifidobacterium (BIF164) P < 0.0001,
Atopobium cluster (ATO 291) P < 0.0001, and
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Desulfovibrio (DSV 687) P < 0.0001 than volun-
teers 2 and 3. In contrast, volunteer 1 had a lower
relative abundance of bacteria staining positive for
Faecalibacterium (FPRAU 655) P < 0.000,
Propionibacterium (Prop 853) P = 0.002, and
Lactobacillus (Lab 158) P < 0.000 Figure 1.
Fermentation of the protein/amino acid and
carbohydrate substrates resulted in changes in bac-
terial groups. Low tyrosine medium induced no
significant bacteriological changes whilst high tyr-
osine medium led to an increase in total bacteria
after 4h fermentation compared with baseline. The
addition of FOS to low tyrosine medium resulted
in significant increases in bifidobacteria at 4h and
of total bacteria and C. histolyticum group at 8 h
when compared to baseline. At 48h in the low
tyrosine with FOS treatment there were more bac-
teroides, compared to the blank vessel
Supplementary data table 1.
In the presence of FOS, the fermentation of
high tyrosine resulted in significant increases in
bacteria within the E. rectales group at t4; lac-
tobacilli at t8 and Roseburia at t 24 as com-
pared to t0. When compared to the blank vessel
fermentation of high tyrosine with FOS resulted
in more total bacteria, bacteria in the
Atopobioum group and members of the
Faecalibacterium prausnitzii group.
Supplementary data table 1.
Supplementary albumin led to a reduction
from baseline in the abundance of bacteria
staining positive clostridia cluster IX at t4,
increased bacteroides at t8 and increased
Atopobium at t30. Compared to the blank ves-
sel, albumin lead to enhanced lactobacilli at t30
and reduced DSV following 48 hours fermenta-
tion. Fermentation of soybean protein resulted
in no significant changes of the groups moni-
tored Supplementary data table 1
Fermentation of FOS resulted in increases in
bacteroides after 4h, bifidobacteria and bacter-
oides after 30 h and total bacteria after 48 h as
compared to t0. When compared to the blank
vessel, FOS resulted in significant increases in
bifidobacteria after 30 h, total bacteria after 8 h
and Atopobium after 48 hours fermentation.
Fermentation of peptone resulted in increases
in E. rectales group after 8 h fermentation and
total bacteria and Roseburia after 24 hours.
Supplementary data table 1.
Figure 1. A, B and C: Microbial differences in starting inoculate composition used within in vitro batch culture fermentation from
three donor samples. BIF- Bif164 positive count, LAB- Lab158 positive count, BAC- Bac 303 positive count, EREC- Erec 482 positive
count, RREC- Rrec584 positive count, ATO- Ato 291 positive count, PRO- Prop853 positive count, FPRAU- Fprau647 positive count,
DSV- Dsv687 positive count, CHIS- Chis150 positive count (see Table1).
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Cresol, phenol and indole
There was considerable inter-individual variation
in the synthesis of organic metabolites in the
batch culture fermentation supernatants accord-
ing to the donor inoculum used. For the pur-
poses of clarity, Figure 2 shows metabolites
produced with inoculate from volunteer 1 only,
and shows variation in the production of pro-
teolytic metabolites in fermentation supernatants
at 30 hours, using different fermentation sub-
strates (three biological replicates with the same
faecal donor). (See supplementary Figure 1 for a
comparison of inter-individual metabolite pro-
duction). P-cresol was produced in the highest
concentrations using a basal medium supple-
mented with a mixture of FOS (1.5% w/w) and
tyrosine (0.3% w/w), reaching a concentration of
17.2 mM. Modest concentrations of p-cresol
were also observed in batch cultures
supplemented with tyrosine alone at high (0.3%
w/w; reaching a concentration of 12 mM) or low
doses (0.003% w/w). Lower concentrations of
p-cresol were produced in fermentations where
the media was supplemented with meat peptone
(0.3% w/w), soy protein (0.3% w/w) or albumin
(0.3% w/w). Using supplementary FOS alone in
the media was not associated with appreciable
p-cresol production (Figure 2A).
The highest concentrations of phenol (9.3 mM)
were observed in the fermentation supernatant
where the culture media was supplemented both
tyrosine and FOS (0.3% w/w and 1.5 % w/w). With
all other substrates phenol concentrations were
much lower (Figure 2B). Indole production was
also greatest (0.8 mM) in the fermentation supple-
mented with the combination of high tyrosine and
FOS and lowest (0.06mM) in fermentations sup-
plemented with FOS alone (Figure 2C).
Figure 2. concentrations of p-cresol (A), phenol (B), indole (C) and total organic acid (D) using from mixed culture fermentation
supernatants at 30 hours using faecal innoculate from volunteer 1; High tyrosine (HT) (0.3:100 w/w), Low tyrosine (LT) (0.003:100 w/
w), High tyrosine with FOS (HT with FOS) (0.3:100 w/w and 1.5:100 w/w), Low tyrosine with FOS (LT with FOS) (0.003:100 w/w and
1.5:100 w/w), Soybean (SB) (0.3:100 w/w),, Peptone meat extract (PM) (0.3:100 w/w), and fructo-oligosaccharide (FOS) (1.5:100 w/w)
after 30hrs incubation. The data presented as mean (± SEM) comparable to the control (n = 3).
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Short chain fatty acids
Inter-individual variation in the synthesis of SCFA
in batch culture fermentation was observed
according to the inoculum used; again for the
purposes of clarity, data are presented here for
volunteer 1 only (see supplementary Figure 2 for
comparisons with volunteers 2 and 3). Figure 3
shows the SCFA concentrations of fermentation
supernatants at 30 h with different supplementary
substrates (three biological replicates with the
same faecal inoculum). The highest production of
SCFA was observed using a basal media supple-
mented with a mixture of tyrosine (0.3% w/w) and
FOS (1.5 w/w), reaching concentrations of 33 mM
of acetate, 9 mM propionate and 6 mM butyrate.
As anticipated, the presence of supplemental FOS
led to higher SCFA concentrations with or without
sources of supplemental nitrogen. The lowest con-
centrations of SCFA were produced in the negative
control, indicating the baseline potential of the
microbiota to produce SCFAs without the addi-
tional of substrates to the media.
Genotoxicity of fermentation supernatants
For clarity, in Figure 4 we present the induction of
DNA damage in HT29 cells by fermentation
supernatants by supplemental substrate for volun-
teer 1. DNA damage was assessed via the COMET
assay following a 24 hour exposure to the filter
sterilised supernatant at 10% of the carrier media.
The highest observed levels of DNA damage were
reported for the fermentation supernatant with the
high tyrosine supplementation (with and without
FOS), they were lowest in the fermentations sup-
plemented with FOS alone. The low tyrosine, low
tyrosine with FOS, albumin, soybean and peptone
meat fermentations all produced moderately gen-
otoxic fermentation samples.
Using the genotoxicity and metabolite data from
all three volunteers we were able to regress the
measured metabolites for individual fermentation
supernatants against the reported genotoxicity. The
best predictors of genotoxicity were p-cresol, acetate
and iso-valerate. Of note however, acetate and iso-
valerate were independently strong correlates of
p-cresol (p = 0.001 and < 0.0001 respectively).
P-cresol genotoxicity and cytotoxicity
The genotoxic effects of increasing concentrations
of p-cresol against both HT29 and Caco-2 cells,
following a 24 h treatment, are shown in Figure 5.
In the top pane of the figure we have plotted cell
viability established via DAPI assay with equivalent
exposures. Cell viability was maintained above 85 %
at each of the doses used although there was a trend
towards increasing cytotoxicity at 3 mM Figure 5.
There was a dose dependent increase in DNA
damage with increasing concentrations of 4- cresol
reaching statistical significance at concentrations
of 3 mM for both cells lines (p = < 0.05) the
observed DNA damage was higher in the HT29
cells than in the Caco-2 cell line.
Figure 3. Concentration of SCFA in mixed culture fermentation supernatants at 30 hours using faecal inoculate from volunteer 1;
High tyrosine (HT) (0.3:100 w/w), Low tyrosine (LT) (0.003:100 w/w), High tyrosine with FOS (HT with FOS) (0.3:100 w/w and
1.5:100 w/w), Low tyrosine with FOS (LT with FOS) (0.003:100 w/w and 1.5:100 w/w), Soybean (SB), Peptone meat extract (PM) and
fructo-oligosaccharide (FOS) (1.5:100 w/w) after 30 hrs incubation. The data presented as mean (± SEM) comparable to the control
(n = 3).
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Internally spiked fermentation supernatants: To
consider the effects of increasing p-cresol concen-
trations within the context of the gut microbial
environment we spiked selected fermentation
supernatants, post-fermentation with either a low
(0.2mM) or high (3mM) doses of p-cresol and
Figure 4. Effect of different fermentation supernatants (High tyrosine (HT), High tyrosine with FOS (HT with FOS), Soybean (SB) and
Peptone meat (PM) on DNA damage for 24 hrs exposure on HT29 cell line. The data presented as mean (± SEM) percentage of DNA
damage comparable to the control (n = 3). * indicate a significant difference compared to the untreated control (Dunnett test;
*p < 0.05).
Figure 5. In the top plane we present the cytotoxicity of p-cresol (cell viability), mean percentage of viable cells comparable to the
control (± SEM). Cells were incubated with increasing concentrations of p-cresol for 24 hours. The lower pane shows DNA strand
breaks in HT29 and Caco-2 cells with increasing p-cresol concentrations: 0, 0.5, 1.5 and 3.0mM after 24 hours. Values are means
± SEM biological replicates. * indicate a significant difference compared to the untreated control (Dunnett test; *p < 0.05).
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assessed genotoxicity against HT29 cells Figure 6.
With higher concentrations of exogenous 4 cresol
we observed an increase in DNA strand breaks.
P-cresol and cell cycle kinetics
We treated both the HT29 (A) and Caco-2 (B)
cells with 4 cresol for 24 hours, before observing
disruptions to cell cycle behaviour Figure 7. There
was a non-linear dose response to p-cresol, with
the changes observed perhaps relating to levels of
DNA damage. At lower exposures of up to 0.5 mM
p-cresol, we observed decreases in the abundance
of cells in G0/G1 with a compensatory increase in
the proportion of cells in S phase, however at
higher concentrations the proportion of cells in
G0/G1 increased significantly relative to the pro-
portion of cells in S phase in both cell lines, sug-
gesting a slight growth promoting effect at lower
doses and G0/G1 growth arrest in response to gen-
otoxic insult at higher doses.
Discussion
In a gut fermentation model, we first observed that
the source of the faecal inoculum influenced the
subsequent metabolic profile of gut model super-
natants given the same supplementary substrate; at
baseline, the faecal inoculate from volunteer 1 was
characterised by a higher relative proportion of
Figure 6. Comet data from fermentation supernatants spiked with a low dose (0.2mM), or a high dose (3mM) of p-cresol. The spiked
supernatants were of High tyrosine (HT), High tyrosine with FOS (HT with FOS), and from soybean (SB) and FOS alone. DNA damage
was assessed after 24 hr incubation in the HT29 cell line. The data presented as mean (± SEM) percentage of DNA damage compared
to the control (n = 3). (Dunnett test; *p < 0.05).
Figure 7. Cell cycle progression of HT29 (A) and Caco-2 (B) cell line treated with 0.2, 0.5, 1.0, 1.5 and 3mM of p-cresol for 24hours.
The percentage of cells in each phase of the cell cycle was determined using flow cytometry to quantify DNA content (n = 4).
Asterisks indicate a significant difference compare to the untreated control (Dunnett test; * p < 0.05, ** p < 0.01, ***p < 0.001).
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Bifidobacterium (BIF 164), Atopobium cluster
(ATO 291) and Desulfovibrio (DSV 687) than
volunteers 2 and 3; and a lower relative abundance
of bacteria staining positive for Faecalibacterium
(FPRAU 655) Propionibacterium (Prop 853) and
Lactobacillus (Lab 158) . The microbial composi-
tion of the faecal inoculate from volunteers 2 and 3
were more closely aligned with each other and
were associated with a lower total production of
p-cresol and other metabolites than the fermenta-
tion supernatants from volunteer 1. A heterogenic
metabolite response between individuals consum-
ing the same foods according to their microbial
composition is well established, but here our
observation provided a rationale for focussing on
metabolite responses in repeat fermentations using
inoculate from one volunteer in our subsequent
analysis of fermentation metabolite interactions
with epithelial cells.
We then demonstrated that both the microbial
composition and the metabolite profiles of the
fermentation supernatants were influenced by the
supplemental fermentation substrates. For exam-
ple, the total bacteria count was significantly
increased following fermentation with medium
supplemented with high levels of tyrosine, high
tyrosine plus FOS, or with peptone meat extract.
(Supplementary Table 1). With the addition of
FOS together with tyrosine, a large increase in
total bacteria was observed, coupled to composi-
tional changes in the abundance of Roseburia, a
key butyrate producing group, but also in
Atopobium and Faecalibacterium prausnitzii. Of
the supplemental protein sources, only albumin
statistically significantly increased the relative
abundance of microbes staining for Lactobacillus
at 30 hours and Desulfovibrio at 48 hours com-
pared to control. These shifts in composition
might be considered relatively minor, and this
may reflect the influence of a relatively high pro-
tein western habitual diet on the donors faecal
inoculum; we know from observational studies,
that higher animal protein diets are associated
with lower microbial diversity, reductions in the
abundance of saccharolytic bacteria and increases
in potentially harmful species such as
Fusobacterium nucleatum, Rhodopseudomonas fae-
calis, Bacteroides vulgatus and Enterococcus
faecalis.,17,18
In contrast to the minor changes in microbial
composition, we observed quite notable changes in
microbial activity as reflected in our metabolite
profiles. Supplementing broths with tyrosine, or
with sources of protein, induced increases in the
production of the proteolytic metabolites, but also
increased the production of acetate and butyrate.
This observation is consistent with the findings of
a recent 3-week intervention study in volunteers
given high protein diets; the volunteers microbial
composition did not change, but there was a tran-
sition towards more proteolytic metabolite
production.19 As expected, supplementing fermen-
tation broth with the prebiotic FOS led to
enhanced synthesis of the saccharolytic metabo-
lites (SCFA) with little effect on the production
of cresol, indole or phenol. Furthermore, combin-
ing prebiotic FOS with supplemental tyrosine in
the fermentation broth led to the highest overall
concentrations of proteolytic end products in any
of our fermentation supernatants. We had antici-
pated that the FOS might suppress the activity of
proteolytic species, in practice the FOS increased
the overall abundance of bacteria, relative to fer-
mentations with tyrosine alone, and this increased
biomass might explain the greater production of
proteolytic products. The SCFA are generally seen
as beneficial products of both proteolytic and sac-
charolytic fermentation; whereas indoles, phenols
and cresol might be viewed as potential toxins
produced during proteolytic fermentation. From
a physiological perspective, the enhanced SCFA
produced when FOS was present with tyrosine
might counter some of the potential harm asso-
ciated with the proteolytic metabolites.20
We next evaluated the fermentation superna-
tants for their capacity to induce DNA damage in
human intestinal cell lines. The substrate influ-
enced the level of DNA damage observed, with
the high tyrosine plus FOS fermentation super-
natant being the most genotoxic. We used a
regression model to evaluate the relationships
between the observed metabolites in the superna-
tant and genotoxicity. From this analysis p-cresol
emerged as the strongest predictor of DNA
damage (Table 2).
p-Cresol can be found in human faeces at con-
centrations of up to 0.5 mM; in vivo p-cresol is
largely absorbed and metabolised to p-cresol
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sulphate appearing in urine at concentrations of
up to 0.3 mM.21 Therefore faecal p-cresol probably
under-represents colonic concentrations. In our in
vitro batch culture fermentation system, p-cresol
concentrations reached up to 17mM, however this
gut model has no mechanism to remove accumu-
lating metabolites that are otherwise absorbed in
the intestinal tract. Probable physiological intest-
inal epithelial exposures are likely in the low mM
range as reported in situ by Smith and
Macfarlane.22
When applied to two different colorectal cul-
tured cell lines at these physiologically relevant
concentrations p-cresol proved cytotoxic at doses
of over 3 mM. Genotoxicity was therefore assessed
at doses of up to 3 mM. We observed a linear dose
dependent increase in DNA damage in both cell
lines but the HT29 cells appeared more sensitive to
p-cresol mediated genotoxicity than the Caco-2
cells. Importantly, we then applied p-cresol to the
cell lines as a spiked component of the gut model
fermentation supernatants, and thus demonstrated
that p-cresol may contribute to genotoxicity as
part of the gut fermentation milieu. Our observa-
tions are consistent with previous work by
Andriamihaja et al, who used the γH2AX assay
and also observed genotoxicity in both HT29 Glc−/+
and LS-174T human colonic cell lines at concentra-
tions of > 1.5 mM.23
We then studied the effects of p-cresol on cell
cycle activity. Again consistent with the obser-
vations of Andriamihaja et al23, at low concen-
trations we observed that the abundance of cells
in S phase was increased in both cell lines with
a subsequent decrease in the abundance of cells
in G0/G1. Assuming this is a mitogenic
response, and not an activation of S phase
arrest, it could explain previously reported
tumour promotion by p-cresol in a classical
murine papilloma study following tumour initia-
tion with 9,10-dimethyl-l-benzanthracene.24 At
higher doses we observed a reduction in the
proportion of cells in S phase and an increase in
proportion of cells in G0/G1 and in G2/M, perhaps
indicating cell cycle arrest in response to DNA
damage.
The models we have employed in this study
are widely used and accepted in mechanistic stu-
dies of dietary exposures related to colorectal
cancer; they represent different aspects of the
carcinogenic process. Having said that, these are
in vitro systems, the anti-cancer defence mechan-
isms of the colonic epithelium are potentially very
different in vivo, and the complexity of the
microbiota and the environment of the gut
lumen confounds our ability to draw firm con-
clusions regarding the potential carcinogenic
effects of p-cresol in vivo.25 To date, one human
randomised crossover trial with high and low
protein diets has reported a weak correlation
between urinary p-cresol excretion and FW
genotoxicity26, whilst the human dietary interven-
tion study by Beaumont et al. reported changes in
the expressions of genes involved in cell death
and cell kinetics in volunteers consuming higher
protein diets, who also showed increased p-cresol
excretion.19 Based on a very small (n = 6 cases)
case control study, Bone and Tamm27 argued that
comparable urinary concentrations of p-cresol
from volunteers with bowel cancer to healthy
controls was evidence that this metabolite is not
affecting CRC risk; ours and other emerging data
might challenge this. Evaluation of p-cresol in
stored urinary samples from existing prospective
cohort studies may help establish the strength of
any relationship with cancer risk and potentially
validate the use of urinary p-cresol as a biomar-
ker of risk for use in intervention studies.
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